Top Media Providers

Investing.com

Google News - Stock Market

Investing.com Australia

Google News - Oil

Google News - Gold

Google News - Forex

Google News - Global Economy

Yahoo Finance

MarketWatch Top Stories

Google News - Federal Reserve

Guardian Business

Crude Oil Prices Today | OilPrice.com

Action Forex

BBC Business

Neurocrine Q3 2026 slides: revenue tops $1.1B, INGREZZA guidance raised

Investing.comBy Investing.com

11/2/2026, 10:54:13 PM

Share:WhatsApp Facebook X (Twitter)Telegram

EXECUTIVE SUMMARY

Neurocrine Q3 2026 slides: revenue tops $1.1B, INGREZZA guidance raised....

Key Takeaways

Neurocrine Q3 2026 slides: revenue tops $1.1B, INGREZZA guidance raised.

Share:WhatsApp Facebook X (Twitter)Telegram

Read Complete Original Article

Published originally on Investing.com

Visit Publisher Site →

OTHER MEDIA SOURCES COVERING THIS STORY

2 Publishers Reporting

Investing.com

Harmonic Q3 2026 slides: revenue surges 64%, guidance raised again

Related News

Finance & Markets13m ago

G20 Chair Rubio focuses on energy and supply chains as EU HR Kallas warns of coercion

G20 Chair Rubio focuses on energy and supply chains as EU HR Kallas warns of coercion INSIGHT EU MONITORING

INSIGHT EU MONITORING

Finance & Markets20m ago

Etsy executive chair Josh Silverman sells $3.9 million in shares

Etsy executive chair Josh Silverman sells $3.9 million in shares....

Investing.com

Finance & Markets21m ago

Guidewire CEO Michael Rosenbaum sells $192,192 in stock

Guidewire CEO Michael Rosenbaum sells $192,192 in stock....

Investing.com

Finance & Markets23m ago

Sasol Share Price Retreats but JSE: SOL Remains Bullish Despite Oil Price Pressure and Debt Concerns

Sasol Share Price Retreats but JSE: SOL Remains Bullish Despite Oil Price Pressure and Debt Concerns FXLeaders

FXLeaders

Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!